Domperidone: a peripherally acting dopamine2-receptor antagonist (Q33637684)

28 July 2017

1 reference

title

Domperidone: a peripherally acting dopamine2-receptor antagonist (English)

1 reference

28 July 2017

J A Barone

1

1 reference

PubMed ID

10332535

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Annals of Pharmacotherapy

28 July 2017

1 reference

28 July 2017

33

1 reference

28 July 2017

4

1 reference

28 July 2017

429-440

1 reference

Gastrointestinal motility disorders in patients with diabetes mellitus

28 July 2017

1 reference

Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus

21 January 2018

1 reference

Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment

21 January 2018

1 reference

Disordered gastric motor function in diabetes mellitus

21 January 2018

1 reference

Prokinetic agents for lower gastrointestinal motility disorders

21 January 2018

1 reference

Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa

21 January 2018

1 reference

Lack of effect of domperidone on gastrin release: evidence for a peripheral activity of the drug

21 January 2018

1 reference

The effect of domperidone on oesophageal emptying in diabetic autonomic neuropathy

21 January 2018

1 reference

Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.

21 January 2018

1 reference

Plasma prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide: a cross-over study in healthy volunteers

21 January 2018

1 reference

Effect of L-dopa in young patients with hypertension

21 January 2018

1 reference

Pharmacokinetics and dose proportionality of domperidone in healthy volunteers.

21 January 2018

1 reference

Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic

21 January 2018

1 reference

Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation

21 January 2018

1 reference

On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man.

21 January 2018

1 reference

Domperidone; secretion in breast milk and effect on puerperal prolactin levels

21 January 2018

1 reference

Diabetic gastroparesis. A critical reappraisal of new treatment strategies

21 January 2018

1 reference

Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine

21 January 2018

1 reference

Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease

21 January 2018

1 reference

Intranasal apomorphine in parkinsonian on-off fluctuations

21 January 2018

1 reference

Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients

21 January 2018

1 reference

Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine

21 January 2018

1 reference

Metoclopramide: pharmacology and clinical application

21 January 2018

1 reference

Extrapyramidal reactions to domperidone.

21 January 2018

1 reference

Domperidone-induced acute dystonia and polycystic ovary syndrome

21 January 2018

1 reference

Refusal of further cancer chemotherapy due to antiemetic drug

21 January 2018

1 reference

Gynaecomastia after long-term administration of domperidone

21 January 2018

1 reference

Domperidone and levodopa in Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18003

1 reference

28 July 2017

1 reference

PubMed ID

10332535